New entries in the Investor Europe portfolio

We are selling Symrise (capital loss 5.42%), Derichebourg (capital loss 1.83%) and Sartorius Stedim Biotech (capital gain 0.06%). These performances are net of brokerage fees and do not take into account the payment of dividends since their entry into the portfolio. Earnings season is about to end, …
© MarketScreener.com 2023